FDA Inspection 883571 — Carter BloodCare, Inc.

Carter BloodCare, Inc. — FEI 1640700

The FDA completed an inspection of Carter BloodCare, Inc. on Jun 11, 2014 in Mount Pleasant, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 11, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mount Pleasant, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.